Tim Rooney - Avita Medical Insider

Avita Medical Limited -- USA Stock  

USD 1.07  0.0462  4.51%

Interim CEO

Mr. Tim Rooney is Chief Financial Officer of Avita Medical Ltd. He was Chief Operating Officer of the Company. Mr. Rooney joined Avita Medical in October 2012 and has more than 25 years experience in financial and operational roles. He served as the Chief Financial Officer and Chief Operating Officer for PDI Enterprises, Inc. in the pharmaceutical wholesale distribution sector, where he was responsible for managing the growth of PDI Enterprises and developing the business into a marketleader. Mr. Rooney has also served as President of a cleantech manufacturerdistributor and President of a non profit organisation. He has experience in strategic planning, mergers and acquisitions, facility design, information systems, logisticsdistribution, and United States Food and Drug Administration regulatory oversight
  CEO Since 2016      
44 1763 269770  http://www.avitamedical.com
Rooney has a BS degree in business administration with an emphasis in finance from California State University, Northridge.

Management Efficiency

The company has return on total asset (ROA) of (97.34) % which means that it has lost $97.34 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (192.26) % meaning that it generated substantial loss on money invested by shareholders.

Similar Executives

Found 1 records

CEO Since

Jose LimMetro Pacific Investments Corpo

Entity Summary

Avita Medical Limited, a regenerative medicine company, develops and distributes regenerative solutions for the treatment of a range of wounds, scars, and skin defects in the Asia Pacific, Europe, the Middle East, Africa, and the Americas. Avita Medical Limited (AVMXY) is traded on OTC Market in USA. It is located in Royston, SG HB and employs 26 people.

Did you try this?

Run Idea Breakdown Now

Idea Breakdown

Analyze constituents of all Macroaxis ideas. Macroaixs investment ideas are predefined, sector-focused investing themes
Hide  View All  Next  Launch Idea Breakdown
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Avita Medical Limited to your portfolio

Top Management

Avita Medical Limited Leadership Team
Damien McDonald, Director, MBA
Lou Panaccio, Chairman
Stella Sung, Executive
Jeremy Cook, Director
Ross Saunders, President
Fiona Wood, Director
Louis Drapeau, Director, CPA
Lorraine Glover, Executive
William Marshall, VP
Matt McNamara, Director
Michael Perry, Director, Ph.D
Suzanne Crowe, Director
Gabriel Chiappini, Executive
Andrew Quick, VP
Ian Macpherson, Chairman
Tim Rooney, CEO
Adam Kelliher, CEO
Troy Barring, COO

Stock Performance

Avita Medical Performance Indicators
Return On Equity(192.26) %
Return On Asset(97.34) %
Current Valuation30.68 M
Price to Earning(3.81) times
Price to Book10.66 times
Price to Sales41.57 times
Revenue950.31 K
Gross Profit517.76 K
EBITDA(10.09 M)
Net Income(9.27 M)